Auven Therapeutics is a private equity firm pursuing an innovative life science investment strategy. Although it utilizes a fund structure, it also has an internal drug development company that allows it to more effectively manage drug development and grow the value of its therapeutic assets.

Auven Therapeutics’ business model addresses a market opportunity that bridges the gap between the lack of funding and often limited development expertise in small biotechnology companies and the shortage of late stage clinical products in established pharmaceutical companies’ pipelines.

For general questions please email

Investors, please click here to log on to the Auven Therapeutics Fund administrator web site. For all technical issues such as accessing the investors website and downloading files, please contact Sungard.